Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics and pharmacogenomics of anticancer agents.

CA: a cancer journal for clinicians - 1 Jan 2000

Huang R Stephanie, Ratain Mark J

Abstract excerpt

Large interindividual variation is observed in both the response and toxicity associated with anticancer therapy. The etiology of this variation is multifactorial, but is due in part to host genetic variations. Pharmacogenetic and pharmacogenomic studies have successfully identified genetic variants that contribute to this variation in susceptibility to chemotherapy. This review provides an overview of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Camptothecin
Share to Clinical Trials as Topic
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorouracil

Share to Irinotecan

Share to Mercaptopurine

Share to Pharmacogenetics

Share to Tamoxifen

Source

Open in PubMed Open full text

Identifiers

PMID: 19147868
DOI: 10.3322/caac.20002
PMCID: PMC3109906

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics and pharmacogenomics of anticancer agents.PMID 19147868Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Cancer pharmacogenetics.Semantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Semantic proximity Read ↗

The use of genomic information to optimize cancer chemotherapy.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.Semantic proximity Read ↗

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.Semantic proximity Read ↗

Part 1: background, methodology, and clinical adoption of pharmacogenetics.Semantic proximity Read ↗

Clinically relevant cancer biomarkers and pharmacogenetic assays.Semantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.Semantic proximity Read ↗

Pharmacogenetics of Drugs Used in the Treatment of CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.